Work

Using the T2DN rat as a model to determine therapeutic efficacy of Serelaxin (recombinant human relaxin‐2) for Diabetic Nephropathy

Year: 2013

Type: article

Source: The FASEB Journal

DOI: 10.1096/fasebj.27.1_supplement.lb889

Authors: Ellen Gillis, Jennifer Mooney, Richard J. Roman, Jan M. Williams, Jennifer M. Sasser

Institution: University of Mississippi Medical Center

Language: English

Topic: Chronic Kidney Disease and Diabetes

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2287582875

FWCI:

Cites:

Cited by:

Related to: 10